US Congress Senate Bill 621 (Prior Session Legislation)

---

Spectrum: Moderate Partisan Bill (Democrat 8-2)
Status: Introduced on March 20 2013 - 25% progression, died in committee
Action: 2013-03-20 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]

Safe Prescribing Act of 2013 - Amends the Controlled Substances Act to remove dihydrocodeinone (hydrocodone) from classification as a schedule III controlled substance. Directs the Attorney General to immediately allow manufacturers and distributors to store hydrocodone combination products in accordance with the physical security requirements for schedule III, IV, and V controlled substances for three years beginning on the date of enactment of this Act. Requires the Comptroller General to submit a report on the reclassification of hydrocodone products under this Act, including: (1) an assessment of the degree to which the reclassification of such products under this Act impacts the ability of patients with legitimate medical needs, particularly those in rural areas and nursing home facilities, to access adequate pain management; and (2) recommendations necessary to address any issues relating to patient access to adequate pain management.

Safe Prescribing Act of 2013

Sen. Joe Manchin [D-WV]	Sen. Dianne Feinstein [D-CA]	Sen. Kirsten Gillibrand [D-NY]	Sen. Tom Harkin [D-IA]
Sen. Mark Kirk [R-IL]	Sen. Amy Klobuchar [D-MN]	Sen. Bill Nelson [D-FL]	Sen. John Rockefeller [D-WV]
Sen. Marco Rubio [R-FL]	Sen. Charles Schumer [D-NY]

Date	Chamber	Action
2013-03-20	Senate	Read twice and referred to the Committee on the Judiciary.

HB1285 (Related) 2013-04-15 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, And Investigations.

Type	Source
Summary	https://www.congress.gov/bill/113th-congress/senate-bill/621/all-info
Text	https://www.congress.gov/113/bills/s621/BILLS-113s621is.pdf